4 viagra and cialis .1 per cent to on hepatitis drug safety concernsbaby boomers account for about two-thirds of the 3.2 million Americans thought to be infected.Shares Achillion Pharmaceuticals Inc., a company that grew the development of a competing hepatitis C treatment, by 24 cents or 4.1 % to 6The Company has recently mid mid-stage clinical trial of IDX184 and is preparing to results from this study report. None of the patients currently treated with the drug. At a conference on Wednesday, said Idenix Chairman and CEO Ronald Renaud, the company very satisfied happy with the safety profile that we have seen to date. .

Hepatitis C is a virus that can lead to life-threatening liver damage and is the leading cause of liver transplants in the United States. The disease is spread through the blood, and through the sharing of through the sharing of intravenous drug needles or having sex with an infected person. There are approximately 3 million Americans with the disease, which remain undetected for many years until the liver is severely damaged, more people as as the aging baby boomer generation.

####of Johns Hopkins University in OFFICE messages and information 901 S. Bond Street London, suites 540 hotels in Baltimore.